Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Population modelling in drug development.

L Sheiner1, J Wakefield

  • 1Department of Laboratory Medicine, University of California, San Francisco, USA.

Statistical Methods in Medical Research
|January 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in <i>Escherichia coli</i> O157:H7 infections - ERRATUM.

Epidemiology and infection·2019
Same author

Responding to Mycobacterium chimaera heater-cooler unit contamination: international and national intersectoral collaboration coordinated in the state of Queensland, Australia.

The Journal of hospital infection·2018
Same author

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.

Epidemiology and infection·2018
Same author

Hyak mortality monitoring system: innovative sampling and estimation methods - proof of concept by simulation.

Global health, epidemiology and genomics·2018
Same author

Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.

Epidemiology and infection·2015
Same author

Detecting signals in pharmacogenomic genome-wide association studies.

The pharmacogenomics journal·2014
Same journal

A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme.

Statistical methods in medical research·2026
Same journal

Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome.

Statistical methods in medical research·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
See all related articles

Population pharmacokinetic/pharmacodynamic models are crucial for drug development. These models predict individual dose-response relationships, aiding in clinical trial design and optimizing drug dosages for diverse patient populations.

Area of Science:

  • Pharmacometrics
  • Drug Development
  • Clinical Pharmacology

Background:

  • Population modeling is essential in modern drug development.
  • Understanding dose-exposure-response relationships is key for effective therapeutics.
  • Individual variability necessitates advanced modeling techniques.

Purpose of the Study:

  • To highlight the significance of population (hierarchical) modeling in drug development.
  • To demonstrate the predictive power of population pharmacokinetic/pharmacodynamic (PopPK/PD) models.
  • To advocate for mechanistic and Bayesian approaches in predictive modeling.

Main Methods:

  • Utilizing population pharmacokinetic/pharmacodynamic (PopPK/PD) modeling.
  • Employing predictive modeling for simulation and trial design.

Related Experiment Videos

  • Applying Bayesian statistical methods for model inference.

    • Main Results:

    • PopPK/PD models reliably predict individualized dose-exposure-response relationships.
    • Models facilitate the design of clinical trials and optimization of dosage regimens.
    • Individualized regimens can be tailored based on patient-specific features like age and sex.

    Conclusions:

    • Population modeling, particularly PopPK/PD, is vital for efficient and effective drug development.
    • Mechanistic and Bayesian approaches enhance predictive accuracy and model utility.
    • These models support optimized trial design and personalized medicine strategies.